23. August 2016

Introduction Increased complications and expense involved in marketing of new drug entities has focused greater attention on development of sustained and controlled release drug delivery systems [1]. The purpose of the systems is to maintain drug concentration in the blood or in target tissues at a desired value as long as possible. To achieve predictable and reproducible release rates, extended duration of activity for short half-life drugs, decreased toxicity, and reduction of required dose,...